British American Tobacco shares rise over 1% as buyback programme reduces share count

Traders Union
All News
Financial News
British american tobacco rises 1.29% today

Highlights

British American Tobacco executed a share buyback of approximately 478,000 shares, directly reducing its share count for capital return.
The buyback and planned cancellation affect free float and may trigger investor disclosure reviews under UK transparency rules.
Technicals show bullish price action above key averages, but mixed momentum and weak trend signals suggest potential near-term consolidation between GBX4,563 and GBX4,718.

Buyback-driven free-float adjustment prompts regulatory disclosures

British American Tobacco has maintained the execution of its ongoing share buyback programme, repurchasing approximately 478,000 ordinary shares between June 29 and July 3, 2026. These shares are scheduled for cancellation as part of the company's capital return strategy, reducing the number of shares outstanding and adjusting the free-float. The resulting change requires some investors to review their disclosure positions under UK transparency requirements.

Anton Kharitonov, expert at Traders Union, emphasizes persistent caution despite recent price gains. He notes that BATS’s share buyback may superficially lift sentiment, but underlying signals point to possible weakness. With the ADX showing a ‘Sell’, muted RSI, and divergence among oscillators, he sees the setup as vulnerable. Short-term downside risk remains if GBX4,588 fails to hold. "Increased optimism from buybacks should be weighed against warning signs in momentum, as the technical picture may not support further upside without real demand."

Viktoras Karapetjanc, expert at Traders Union, views the ongoing share buyback as a testament to British American Tobacco’s robust capital return policy and shareholder focus. He highlights the firm’s ability to trade above all major moving averages and sees the bullish structure as intact. The technical alignment and capital management signal strong institutional confidence. "I believe the consolidation zone sets up the market for further strength, with opportunities for growth if GBX4,652 is breached."

Parshwa Turakhiya, analyst, observes that sentiment is upbeat following the buyback but mixed signals from technicals may temper immediate bullish expectations. Price action near key resistance at GBX4,652 suggests a breakout attempt could spark short-term momentum, yet recent volatility and oscillator divergence signal caution. He sees scope for tactical trades as the stock approaches inflection. "I see flexible setups this week, with swift reaction likely if resistance breaks or support falters."

Bullish trend persists as short-term momentum signals diverge

BATS trades above all key daily moving averages, with the price at GBX4,641 compared to the MA-20 at GBX4,577, MA-50 at GBX4,564, and MA-200 at GBX4,307. This structure affirms bullish momentum in short, medium, and long-term trends, further backed by a bullish MA-50 versus MA-200 alignment. The immediate resistance level stands at GBX4,652, while support is seen at GBX4,588. Among momentum signals, MACD indicates a 'Strong Buy' with a positive bias, although the ADX flashes a 'Sell' and reflects a weak trend. RSI at 49.39 points to mild selling pressure. CCI and Stochastic RSI are neutral, while Bull/Bear Power (BBP) at 39.89 shows buying remains dominant but highlights some overbought risk. The price is close to the session’s high, intraday volatility is 1.39%, and the general tone is firm. Divergence in oscillators and momentum indicators signals a possible inflection point in the near term.

Earlier, analysts noted that British American Tobacco shares were consolidating, with the next decisive move dependent on a clear break above resistance or below support. The latest technical structure and ongoing buyback activity now reinforce that a sustained move beyond GBX4,652 would be a key breakout trigger in the sessions ahead.

Source of Data: BATS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.